Protein profiling on meglumine antimoniate (Glucantime®) sensitive and resistant L. tropica isolates by 2-dimentional gel electrophoresis: A preliminary study

Iranian Journal of Parasitology

Volumn 4, Issue 1, 2009, Pages 8-14

  Hajjaran, H ^a   Mohebali, M ^a   Assareh, A ^a   Heidari, M ^b   Hadighi, R ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH INSTITUTE OF IRAN   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

2 Dimentional gel electrophoresis (2 DE); Glucantime ; Iran; L. tropica; Protein profiling; Resistant; Sensitive

Indexed keywords

ACETONE; MEGLUMINE ANTIMONATE; SILVER NITRATE;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; IRAN; ISOELECTRIC FOCUSING; LEISHMANIA TROPICA; MOLECULAR WEIGHT; NONHUMAN; PARASITE CULTIVATION; PARASITE ISOLATION; PARASITE VIRULENCE; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SILVER STAINING; SKIN LEISHMANIASIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

LEISHMANIA TROPICA;

EID: 67449113796     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Control of the leishmaniasis. Report of a WHO Expert Committee. Geneva, World Health Organization, 1990:159 (WHO Technical Report Series, No.793).
2. Nadim A. Leishmaniases. In: Azizi F., eds. Epidemiology and control of prevalent diseases in Iran, 2nd ed. Endocrine and Metabolism Research Center. 2000, 524-534 (In Farsi).
3. Yaghoobi Ershadi MR, Akhavan AA, Zahrai AR. Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Mediterr Health J. 2004;9(4):65-72.
4. Hajjaran H, Mohebali M. Razavi MR, Rezaei S, Kazemi B, Edrissian GhH, Mojtabavi J, Hooshmand B. Identification of Leishmania species isolated from human cutaneous leishmaniasis, using RAPD-PCR. Iranian J Publ Health. 2004;33(4):8-15.
5. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006; 19(1):111-126.
6. Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Nad Med J India. 2005;18:131-133
7. Mohebali M. Resistance of Leishmania tropica Iranian strain to meglumine antimoniate (Glucanyime®): in vivo and in vitro methods. WHO-EM/TDR/110/E, Final Report Summaries 2003-2004.
8. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLOS Med. 2006; 3: 0659-0667.
9. Ashutosh, Sundar Sh, Goyal N. Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol. 2007;56:143-153.
10. Graves PR, Haystead TAJ. Molecular Biologists's Guide to Proteomics. Microbiol Mol Biol Rev. 2002;66:38-63.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-685.
12. Hajheidari:M, Elvazi A, Buchanan B, Wong HJ, Majidi I, Hosseini Salekdeh Gh. Proteomics uncover a role for rodex in drought tolerance in wheat. J Proteom Res. 2007;6:1451-1460.
13. Shevehenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver- stained polyacrylamide gels. Anal Chem. 1995; 68(5):850-858.
14. Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-254.
15. Baharvand H, Fathi A, Hoof DV, Hosseini salekdeh Gh. Trends in stem cell proteomics. Stem Cells. 2007; http://StemCells.com
16. Gazanchian A, Hajheidari M, Khoshkholgh Sima N, Hosseini salekdeh Gh. Proteom response of Elymus elongatum to severe water stress and recovery. J Exp Botany. 2007;58(2):291-300.
17. Hadighi R, Boucher P, Khamesipour A, Meamar AR, Roy G, Ouellette M, Mohebali M. Glucantim resistant L. tropica from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmanial drugs. Parasitol Res. 2007;101(5): 1319-22.
18. Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M. A proteomics screen implicates HSP 83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by Modulating Drug -induced Programmed cell death. Mol Cell Proteomics. 2007;6(1): 88-101.
19. Drummelsmith J, Girand I, Trudel N, Ouellette M. protein expression analysis of L. major reveals novel roles for methionine adenosyl and s- adenosyl in methotrexate resistance. J Biol Chem. 2004;32: 279.
20. Guimond C, Trudel N, Brochu C, Marquis N, Fadili AE, avi R,Briand G,Richard D, Messier N, Papadopoulou B, corbeil J, Bergeron M, Legare D, Ouellette M. Modulation of gene expression in drug resistant mutants as determined by targeted DNA microarrays. Nuc Acid Res. 200,3; 31(20): 5886-5896.
21. Drummelsmith J, Brochu V,Girand I, Messier N, Ouellette M. Proteom mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol Cell Proteomics. 2003;2(3):146-155.
22. Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Natl Med J India. 2005;18:131-133.
23. Cohen AM, Rumpel K, Coombs GH, Wastling JM. Characterization of global protein expression by 2-DE and mass spectrometry. Proteomics of Toxoplasma gondii. Int J Parasitol. 2002;32:39-51.
24. Lasonder E, Ishihama Y, Andersen JS, Vermunt AM, Pain A, Sauerwein RW, Eling WM, Hall N, Waters AP, Stunnenberg HG et al. Analysis of the plasmodium falciparum proteome by high accuracy - mass spectrometry. Nature. 2002;419: 537-542.
25. Reynolds KB, Fang CM, Xiadong C, Lynn S. Comparative Two-Dimensional Gel Electrophoresis Maps for Promastigotes of Leishmania amazonensis and L. major. Brazilian J Infec Dis. 2006;10(1): 1-6.
26. El Fakhry Y, Ouellette M, Papadopoulou B. A proteomic approach to identify developmentally regulated proteins in Leishmania infantum. Proteomics. 2002;2:1007-1017.
27. Acestor N, Masina S, Walker J Saravia NG et al. Establishing two dimensional gels for the analysis of Leishmania proteomes. Proteomics. 2002;2:877-879.